# FDA Inspection 1108979 - RD2RX, LLC - October 03, 2019

Source: https://www.keypedia.com/records/fda_inspections/rd2rx-llc/be9f9f23-239e-4eed-ae6c-06fde7a16ec3
Source feed: FDA_Inspections

> FDA Inspection 1108979 for RD2RX, LLC on October 03, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108979
- Company Name: RD2RX, LLC
- Inspection Date: 2019-10-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268287 - 2025-04-21](https://www.keypedia.com/records/fda_inspections/rd2rx-llc/2eee43f1-d0e4-43fd-9de3-2396b73957a4)
- [FDA Inspection 1268287 - 2025-04-21](https://www.keypedia.com/records/fda_inspections/rd2rx-llc/8d665af7-03ea-42f1-a17e-89fc8bdb92c7)

Company: https://www.keypedia.com/companies/rd2rx-llc/9e7cb4b2-4f5a-469b-87f6-968c59264669

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c